Neurological conditions

Neurological symptoms common in COVID-19 patients, researchers say

Neurological symptoms are common in patients with COVID-19, particularly if they have a severe infection, research published in JAMA Neurology suggests.…

A day in the life of a pharmacist administering botulinum injections

Eric Bazuaye uses his specialist pharmacist knowledge and practical expertise to provide unique relief to patients diagnosed with neurological disorders.…

Considerations for the inpatient management of Parkinson’s disease

Recognising and managing certain complications of Parkinson’s disease can help improve care and reduce the risk of admission for people living with the condition.…

Trial confirms antiepileptic effects of fenfluramine in children with Dravet syndrome

Children with Dravet syndrome, a severe form of epilepsy that is resistant to treatment, experience fewer seizures when treated with fenfluramine, a phase III trial published in The Lancet has confirmed.…

Multimodal exercise improves Parkinson’s disease symptoms

Exercise plans involving both physical and mental challenges, may improve outcomes in people with Parkinson’s disease, research presented at the Future Physiology conference has shown.…

Drug interaction may explain cannabidiol’s effects on severe form of epilepsy

A drug–drug interaction between cannabidiol and clobazam may explain why cannabidiol reduces the frequency of seizures in patients with a severe form of epilepsy, researchers have reported.…

Accord’s phenytoin sodium 100mg capsules out of stock until early May 2020

The pharmaceutical manufacturer Accord has said that its phenytoin sodium NRIM 100mg capsules, used for the management of epilepsy, will be out of stock until early May 2020.…

European Commission approves first CBD medicine for severe epilepsy

A cannabidiol-based medicine for severe epilepsy has been given marketing approval by the European Commission.…

NICE cannabis guidance could ‘detract’ from doctors considering prescribing for epilepsy, RPS warns

NICE cannabis guidance could deter doctors from prescribing for epilepsy, RPS warns Source: Shutterstock.com Cannabis-based medical products are legal for use in the treatment of some forms of severe treatment-resistant epilepsy Draft guidance is…

Shortage of epilepsy medicine to continue until end of October, manufacturer says

All strengths of the epilepsy medicine Gabitril will be out of stock in the UK until the end of October 2019, the drug’s manufacturer has said.…